Live feed16:02:00·322dPRReleasevia QuantisnowBioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPSByQuantisnow·Wall Street's wire, on your screen.BMRN· BioMarin Pharmaceutical Inc.Health Care
